Registry for evaluating a comprehensive approach to autoimmune disorders

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational registry aims to assess the effectiveness of the AndHealth program, which combines pharmacological and non-pharmacological therapies tailored to individual patients with autoimmune disorders. Participants will be monitored over a period of up to five years, with evaluations based on validated labs, patient-reported outcomes, and medication usage. The focus is on conditions such as rheumatoid arthritis, psoriatic arthritis, psoriasis, and ankylosing spondylitis, allowing for a personalized treatment approach under the guidance of licensed physicians and health coaches.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Adults 18 to 70 years of age
2. Able to understand and write English
3. Voluntarily consent to the study and understand its nature and purpose including potential risks and side effects
4. Documented diagnosis and current use/recommendation for biologic or DMARD medications to treat rheumatoid arthritis, psoriatic arthritis, psoriasis, or ankylosing spondylitis.

Exclusion Criteria:

1. Pregnant, breastfeeding, or planning to become pregnant in the next 12 months
2. Advanced liver or kidney disease
3. Previous organ transplant or awaiting organ transplant
4. Actively being treated for cancer
5. Poorly-controlled mental illness (i.e., schizophrenia, bipolar, current eating disorder)
6. Has a terminal illness
7. Current opioid use

Where it's running

• AndHealth
  Columbus, Ohio, United States Recruiting

Study contacts

• Principal investigator: Myles Spar, MD — AndHealth
• Study coordinator: Sonja Horner
• Email: shorner@andhealth.com
• Phone: 614-697-3296

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• HB0017 Injection safety and PK in low-weight adults at different injection sites

  This early-phase study tests a single subcutaneous HB0017 injection in healthy, low-weight adults and compares how the body processes the drug when injected at different sites.

  Recruiting Phase 1 Huabo Biopharm Co., Ltd. · Hangzhou, Zhejiang · NCT07920861

• Guselkumab in Breast Milk for Lactating Women on Guselkumab

  This study tests how much guselkumab is present in the breast milk of lactating women who are already receiving guselkumab for their approved conditions.

  Recruiting Phase 4 Janssen Research & Development, LLC · Chapel Hill, North Carolina · NCT07654751

• Effects of phytocannabinoids on immune response in chronic inflammatory diseases

  This study is testing whether phytocannabinoids like CBD and THC can help improve the immune response in people with chronic inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease.

  Recruiting Centre Hospitalier Régional d'Orléans · Orléans · NCT06842316

• Study on how diet affects autoimmune diseases in rheumatology patients

  This study looks at how changing to a healthier diet, like the Mediterranean diet, might help people with autoimmune diseases feel better and manage their symptoms.

  Recruiting University of Central Florida · Orlando, Florida · NCT06339957

• Advanced imaging techniques for diagnosing joint diseases

  This study is testing a new type of imaging called photon-counting CT to see if it can better diagnose joint diseases like rheumatoid arthritis compared to traditional methods like MRI and X-rays.

  Recruiting at 3 sites Semmelweis University · Budapest and 2 other locations · NCT05657847

• A platform for collecting health data on ME/CFS and Long Covid

  This study is trying to collect health information from adults with ME/CFS and Long Covid to help researchers better understand these conditions and improve future treatments.

  Recruiting Brain Inflammation Collaborative · Delafield, Wisconsin · NCT04806620

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.